Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China

被引：0
|
作者：
Huang, Kun [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Pediat, Sch Med, 1367 Wenyi West Rd, Hangzhou 311121, Zhejiang, Peoples R China
来源：
ADVANCES IN THERAPY | 2024年 / 41卷 / 04期
关键词：
Hemophilia A; Pharmacokinetics; Cost-effectiveness; Prophylaxis; Bleeding;
D O I：
10.1007/s12325-024-02786-0
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1759 / 1761
页数：3
相关论文
共 50 条
  • [1] Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
    Kun Huang
    Advances in Therapy, 2024, 41 : 1759 - 1761
  • [2] Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
    Congling Gu
    Hui Huang
    Yi Han
    Advances in Therapy, 2022, 39 : 3777 - 3788
  • [3] Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China
    Gu, Congling
    Huang, Hui
    Han, Yi
    ADVANCES IN THERAPY, 2022, 39 (08) : 3777 - 3788
  • [4] A Response to: Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China”
    Congling Gu
    Yi Han
    Advances in Therapy, 2024, 41 : 1762 - 1764
  • [5] A Response to: Letter to the Editor Regarding "Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China"
    Gu, Congling
    Han, Yi
    ADVANCES IN THERAPY, 2024, 41 (04) : 1762 - 1764
  • [6] Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis
    Kraemmer, Daniel
    Koenigsbruegge, Oliver
    Moik, Florian
    Wildner, Brigitte
    Ay, Cihan
    Pabinger, Ingrid
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (12) : 3432 - 3449
  • [7] Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Moderate or Severe Hemophilia A in China
    Zhou, Yaohan
    Li, Zhengping
    Liu, Guoqing
    Chen, Zhenping
    Yao, Wanru
    Li, Gang
    Zhen, Yingzi
    Cheng, Xiaoling
    Ai, Di
    Huang, Kun
    Cao, Wang
    Wu, Runhui
    CLINICAL THERAPEUTICS, 2024, 46 (12) : 1010 - 1015
  • [8] Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A
    Iannazzo, Sergio
    Cortesi, Paolo A.
    Crea, Roberto
    Steinitz, Katharina
    Mantovani, Lorenzo G.
    Gringeri, Alessandro
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (06) : 425 - 430
  • [9] Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Hemophilia B Without Inhibitors in China
    Liu, Guoqing
    Xin, Qing
    Chen, Zhenping
    Li, Lanting
    Chen, Ting
    Wu, Runhui
    CLINICAL THERAPEUTICS, 2021, 43 (09) : 1536 - 1546
  • [10] Pharmacokinetic-guided prophylaxis improved clinical outcomes in paediatric patients with severe haemophilia A
    Huang, Kun
    Zhen, Yingzi
    Li, Gang
    Wu, Xinyi
    Chen, Zhenping
    Wu, Runhui
    HAEMOPHILIA, 2021, 27 (04) : E450 - E457
12345